0001562180-21-004412.txt : 20210621
0001562180-21-004412.hdr.sgml : 20210621
20210621201855
ACCESSION NUMBER: 0001562180-21-004412
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210617
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chard Daniel R
CENTRAL INDEX KEY: 0001289557
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31573
FILM NUMBER: 211032685
MAIL ADDRESS:
STREET 1: NU SKIN ENTERPRISES, INC.
STREET 2: 75 WEST CENTER STREET
CITY: PROVO
STATE: UT
ZIP: 84601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIFAST INC
CENTRAL INDEX KEY: 0000910329
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
IRS NUMBER: 133714405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11445 CRONHILL DRIVE
CITY: OWINGS MILLS
STATE: MD
ZIP: 21117
BUSINESS PHONE: 7327640619
MAIL ADDRESS:
STREET 1: 11445 CRONHILL DRIVE
CITY: OWINGS MILLS
STATE: MD
ZIP: 21117
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHRITE INC
DATE OF NAME CHANGE: 19951120
FORMER COMPANY:
FORMER CONFORMED NAME: XX
DATE OF NAME CHANGE: 19950619
FORMER COMPANY:
FORMER CONFORMED NAME: 00
DATE OF NAME CHANGE: 19950619
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-06-17
false
0000910329
MEDIFAST INC
MED
0001289557
Chard Daniel R
C/O MEDIFAST, INC.
100 INTERNATIONAL DRIVE, 18TH FLOOR
BALTIMORE
MD
21202
true
true
false
false
Chairman & CEO
Common Stock
2021-06-17
4
S
false
600.00
259.3225
D
112091.00
D
Common Stock
2021-06-17
4
S
false
1000.00
260.3738
D
111091.00
D
Common Stock
2021-06-17
4
S
false
1000.00
261.456
D
110091.00
D
Common Stock
2021-06-17
4
S
false
600.00
262.54
D
109491.00
D
Common Stock
2021-06-17
4
S
false
863.00
263.3124
D
108628.00
D
Common Stock
2021-06-17
4
S
false
213.00
264.3453
D
108415.00
D
Common Stock
2021-06-17
4
S
false
287.00
265.2889
D
108128.00
D
Common Stock
2021-06-17
4
S
false
802.00
267.0011
D
107326.00
D
Common Stock
2021-06-17
4
S
false
502.00
268.0049
D
106824.00
D
Common Stock
2021-06-17
4
S
false
298.00
269.1175
D
106526.00
D
Common Stock
2021-06-17
4
S
false
200.00
270.095
D
106326.00
D
The shares are sold pursuant to a 10b5-1 Plan entered into by the Reporting Person on March 2, 2021
This transaction was executed in multiple trades at prices ranging from $267.73 USD to $268.71 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $268.87 USD to $269.61 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $270.09 USD to $270.10 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $258.74 USD to $259.66 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $259.83 USD to $260.82 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $260.94 USD to $261.92 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $262.00 USD to $262.96 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $263.00 USD to $263.48 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $264.10 USD to $265.07 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $265.10 USD to $265.79 USD; the price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $266.66 USD to $267.54 USD; the price reported above reflects the weighted average sale price.
/s/ Jason L. Groves, attorney-in-fact
2021-06-21